Hundreds of people are set to benefit as NICE recommends acalabrutinib for newly diagnosed mantle cell lymphoma and chronic lymphocytic leukaemia.
Around 6,600 people in England with a serious heart condition will be able to access a new treatment following simultaneous MHRA authorisation and NICE approval today.
A specialist machine that keeps donated lungs alive outside the body has been conditionally recommended in draft NICE guidance in a move that could unlock hundreds of organs for transplants.
People in England with a type of chronic heart failure could benefit from a new treatment option. Our final draft guidance recommends finerenone for adults with chronic heart failure with preserved or mildly reduced ejection fraction.
Our annual report and accounts covering April 2025 to March 2026 highlight our key achievements. Find out how we’re delivering against the 10 Year Health plan, and how we’re becoming more relevant, timely, impactful and usable.
A groundbreaking approach to monitoring heart failure patients remotely has reduced unnecessary hospital admissions by 58%, improving patient experience and saving the NHS £4,158 per patient.
Modern Service Frameworks aim to make high-quality care more consistent across England. Deputy chief medical officer, Judith Richardson explains how NICE guidance is helping turn evidence into practical service improvement.
Artificial intelligence has huge potential to improve health and care, but its use must be safe, effective and fair. In this blog, chief executive Jonathan Benger explains how NICE's new AI delivery plan will support responsible adoption in the NHS, ensuring AI brings real benefits for patients.
